Glucagon therapeutics: Dawn of a new era for diabetes care-Reference-Cited by-同舟云学术

Glucagon therapeutics: Dawn of a new era for diabetes care

Author:

Davidson Jaime A.¹,Holland William L.¹,Roth Michael G.²,Wang May-yun¹,Lee Young¹,Yu Xinxin¹,McCorkle Sara K.³,Scherer Philipp E.¹,Unger Roger H.¹³

Affiliation:

1. Touchstone Diabetes Centre, Department of Internal Medicine; University of Texas Southwestern Medical Centre; Dallas TX USA

2. Department of Biochemistry; University of Texas Southwestern Medical Centre; Dallas TX USA

3. VA North Texas Health Care System; Dallas TX USA

Funder

REMD Therapeutics Inc

Synalpha Therapeutics LLC

Amylin Pharmaceuticals Inc

Veteran's Administration merit grant

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference24 articles.

4. Paracrinology of islets and the paracrinopathy of diabetes;Unger;Proceedings of the National Academy of Sciences of the United States of America,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Incretin and glucagon receptor polypharmacology in chronic kidney disease;American Journal of Physiology-Endocrinology and Metabolism;2024-06-01